Ceragenix Pharmaceuticals

Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006
Genetic Engineering News - May 15 at 5:15 EDT Ceragenix Pharmaceuticals, Inc. (OTCBB: CGXP - News) is a biopharmaceutical company that discovers, develops and commercializes novel anti-infective drugs based on its proprietary class of compounds, Ceragenins(TM) (or CSAs

Latest News
dBusinessNews.com - Study to Compare EpiCeram(R) to Mid-Strength Topical Steroid in Treatment of Children with Moderate-to-Severe Eczema DENVER -- Ceragenix Pharmaceuticals, Inc., a biopharmaceutical company focused on Allied Motion Makes 2006 FORTUNE Small Business

Latest News
dBusinessNews.com - Study to Compare EpiCeram(R) to Mid-Strength Topical Steroid in Treatment of Children with Moderate-to-Severe Eczema DENVER -- Ceragenix Pharmaceuticals, Inc., a biopharmaceutical company focused on Allied Motion Makes 2006 FORTUNE Small Business

Latest News
dBusinessNews.com - DENVER -- America's best respected radio frequency identification (RFID) consulting Denver: FDA Grants Ceragenix's Request for Cerashield(TM) to be Reviewed as a Device; Ceragenix to Seek Expedited Review DENVER -- Ceragenix Pharmaceuticals, Inc